A previous meta-analysis of Li et al. also showed that a high CD8 expression is associated with better survival in cancer patients treated with immunotherapy, such as melanoma, non-small cell lung cancer, and breast cancer, which shows the clinical importance of the use of CD markers in the treatment of cancer [105]. Here, CD8A is linked to non-small cell lung carcinoma.